MedTrace Logo

Use Test: Dermowas Body Lotion pH 4 vs. pH 5.8

NCT04538183 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2020-09-04

No results posted yet for this study

Summary

The objective of the study was to examine whether normalizing of the pH by acidification through topical treatment helps to strengthen the skin barrier, to induce epidermal differentiation and to reduce inflammation in healthy individuals.

Conditions

  • Healthy

Interventions

OTHER

WO 5000

WO 5000

OTHER

WO 5001

WO 5001

Sponsors & Collaborators

  • Dr. August Wolff GmbH & Co. KG Arzneimittel

    lead INDUSTRY

Principal Investigators

  • Sören Merker, Dr. · Dr. August Wolff GmbH & Co. KG Arzneimittel

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-04
Primary Completion
2018-03-03
Completion
2018-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04538183 on ClinicalTrials.gov